MRVI
Maravai Lifesciences Holdings, Inc.Company with tickers: MRVI
CIK
1823239
CUSIP
56600D107
Shares Outstanding
147,506,164
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $46,850,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Cost of Revenue | $39,125,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Gross Profit | $7,725,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Operating Expenses | — | ||||
| Research & Development | $4,888,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Operating Income | $-49,162,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-29,945,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $-0.21 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $-0.21 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |